4D pharma plc announced that it expects to receive $30 million in funding from Oxford Finance LLC
On the same date, the company received $12.5 million in its first tranche. The company also issued a warrant, exercisable in five years, which entitles the holder to subscribe for 212,568 new ordinary shares in the company at $1.18 per share. The company will receive remaining $7.5 million and $10 million in tranches dependent on the achievement of certain milestones.